Rac GTPase Activating Protein 1 (RACGAP1) (N-Term) Peptid
RACGAP1
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN982596
Kurzübersicht für Rac GTPase Activating Protein 1 (RACGAP1) (N-Term) Peptid (ABIN982596)
Target
RACGAP1
(Rac GTPase Activating Protein 1 (RACGAP1))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-RACGAP1 antibody (Catalog #: ARP32595_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- RACGAP1 (Rac GTPase Activating Protein 1 (RACGAP1))
-
Hintergrund
-
Rho GTPases control a variety of cellular processes. There are 3 subtypes of Rho GTPases in the Ras superfamily of small G proteins: RHO, RAC, and CDC42. GTPase-activating proteins (GAPs) bind activated forms of Rho GTPases and stimulate GTP hydrolysis. T
Alias Symbols: HsCYK-4, ID-GAP, MgcRacGAP, CYK4
Protein Interaction Partner: AURKB,CHN2,KIF23,MAP3K10,MAP3K4,NRAS,PRC1,PRSS23,RACGAP1,RND2,SH3RF1,SLC16A10,SLC26A8,TUBA4A,TUBG1,VAV1,YWHAB,YWHAG,AURKB,GRB2,PRSS23,RND2,SFN,SLC26A8,Sh3rf1,VAV1,YWHAB,YWHAG
Protein Size: 632 -
Molekulargewicht
- 71 kDa
-
Gen-ID
- 29127
-
NCBI Accession
- NM_013277, NP_037409
-
UniProt
- Q9H0H5
Target
-
Sie sind hier:
